Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
Public ClinicalTrials.gov record NCT02135029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-blind, Double-dummy, Randomized, Placebo And Active Controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Dyslipidemia Who Are Intolerant To Statins
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a multicenter, double blinded, active and placebo controlled randomized clinical trial to demonstrate a superior lipid lowering effect of Bococizumab (PF-04950615; RN316) compared to placebo in subjects who are statin intolerant.
Study identification
- NCT ID
- NCT02135029
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 184 participants
Conditions and interventions
Conditions
Interventions
- Bococizumab (PF-04950615;RN316) Drug
- Atorvastatin Drug
- Placebo for Bococizumab (PF-04950615;RN316) Other
- Placebo for atorvastatin Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Actual)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Nov 2015 (Actual)
- Last update posted
- Dec 14, 2017
2014 – 2015
United States locations
- U.S. sites
- 31
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Creekside Endocrine Associates, PC | Denver | Colorado | 80209 | — |
| Bridgeport Hospital | Bridgeport | Connecticut | 06610 | — |
| Watson Clinic Center for Research, Inc. (for Drug Shipment only) | Lakeland | Florida | 33805 | — |
| Cardiovascular Research Center Of South Florida | Miami | Florida | 33173 | — |
| St. Johns Center for Clinical Research | Ponte Vedra | Florida | 32081 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| East-West Medical Research Institute | Honolulu | Hawaii | 96814 | — |
| NorthShore University HealthSystem - Evanston Hospital | Evanston | Illinois | 60201 | — |
| Health Care Centers of Illinois Mokena Medical Commons | Mokena | Illinois | 60448 | — |
| Advocate Medical Group Cardiology | Normal | Illinois | 61761 | — |
| Advocate Medical Group Midwest Heart Specialists | Park Ridge | Illinois | 60068 | — |
| Prairie Education & Research Cooperative (Administrative) | Springfield | Illinois | 62701 | — |
| Prairie Heart Institute | Springfield | Illinois | 62701 | — |
| St. John's Hospital | Springfield | Illinois | 62769 | — |
| The University of Iowa - College of Public Health - Preventive Intervention Center | Iowa City | Iowa | 52242 | — |
| The Iowa Clinic, PC | West Des Moines | Iowa | 50266 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Crescent City Clinical Research Center | Metairie | Louisiana | 70006 | — |
| Allina Health System, dba Abbott Northwestern Hospital | Minneapolis | Minnesota | 55407 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Dayton Heart Center | Dayton | Ohio | 45414 | — |
| Clinical and Translational Research Center, Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Perelman Center for Advanced Medicine | Philadelphia | Pennsylvania | 19104 | — |
| Berks Cardiologists, Ltd. | Wyomissing | Pennsylvania | 19610 | — |
| PMG Research of Bristol | Bristol | Tennessee | 37620 | — |
| PMG Research of Knoxville, LLC | Knoxville | Tennessee | 37912 | — |
| San Antonio Military Medical Center | Fort Sam Houston | Texas | 78234-6200 | — |
| Office of Michelle Zaniewski MD., PA. | Houston | Texas | 77090 | — |
| Utah Cardiology, P.C. | Layton | Utah | 84041 | — |
| Aspen Clinical Research LLC | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02135029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02135029 live on ClinicalTrials.gov.